The company focuses on implantable ports used in cancer treatment protocols and specialty catheters used in hemodialysis and stem cell apheresis procedures. With the broadest product lines in these categories and the largest direct sales force dedicated to vascular access products, HMP(TM) aims to capture a significant share of the estimated $1.3 billion global market for vascular access products.